170 related articles for article (PubMed ID: 33201835)
1. A glycolysis-related gene expression signature in predicting recurrence of breast cancer.
Tang J; Luo Y; Wu G
Aging (Albany NY); 2020 Nov; 12(24):24983-24994. PubMed ID: 33201835
[TBL] [Abstract][Full Text] [Related]
2. A glycolysis-related gene signature predicts prognosis of patients with esophageal adenocarcinoma.
Kang H; Wang N; Wang X; Zhang Y; Lin S; Mao G; Liu D; Dang C; Zhou Z
Aging (Albany NY); 2020 Nov; 12(24):25828-25844. PubMed ID: 33234735
[TBL] [Abstract][Full Text] [Related]
3. An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment.
Tang J; Cui Q; Zhang D; Liao X; Zhu J; Wu G
J Cell Mol Med; 2019 Aug; 23(8):4980-4990. PubMed ID: 31124293
[TBL] [Abstract][Full Text] [Related]
4. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel cell glycolysis related gene signature predicting survival in patients with breast cancer.
Jiang F; Wu C; Wang M; Wei K; Wang J
Sci Rep; 2021 Feb; 11(1):3986. PubMed ID: 33597614
[TBL] [Abstract][Full Text] [Related]
6. Metabolic gene signature for predicting breast cancer recurrence using transcriptome analysis.
Feng J; Ren J; Yang Q; Liao L; Cui L; Gong Y; Sun S
Future Oncol; 2021 Jan; 17(1):71-80. PubMed ID: 33397130
[No Abstract] [Full Text] [Related]
7. An immune-related prognostic signature for predicting breast cancer recurrence.
Tian Z; Tang J; Liao X; Yang Q; Wu Y; Wu G
Cancer Med; 2020 Oct; 9(20):7672-7685. PubMed ID: 32841536
[TBL] [Abstract][Full Text] [Related]
8. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
[TBL] [Abstract][Full Text] [Related]
9. Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients.
Kuang XY; Chen L; Zhang ZJ; Liu YR; Zheng YZ; Ling H; Qiao F; Li S; Hu X; Shao ZM
Oncotarget; 2015 Sep; 6(26):22227-38. PubMed ID: 26087399
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel glycolysis-related gene signature that can predict the survival of patients with lung adenocarcinoma.
Liu C; Li Y; Wei M; Zhao L; Yu Y; Li G
Cell Cycle; 2019 Mar; 18(5):568-579. PubMed ID: 30727821
[TBL] [Abstract][Full Text] [Related]
11. The phosphorylation-specific association of STMN1 with GRP78 promotes breast cancer metastasis.
Kuang XY; Jiang HS; Li K; Zheng YZ; Liu YR; Qiao F; Li S; Hu X; Shao ZM
Cancer Lett; 2016 Jul; 377(1):87-96. PubMed ID: 27130664
[TBL] [Abstract][Full Text] [Related]
12. An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer.
Sánchez-Navarro I; Gámez-Pozo A; Pinto A; Hardisson D; Madero R; López R; San José B; Zamora P; Redondo A; Feliu J; Cejas P; González Barón M; Angel Fresno Vara J; Espinosa E
BMC Cancer; 2010 Jun; 10():336. PubMed ID: 20584321
[TBL] [Abstract][Full Text] [Related]
13. A prognostic 10-lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients.
Tang J; Ren J; Cui Q; Zhang D; Kong D; Liao X; Lu M; Gong Y; Wu G
J Cell Mol Med; 2019 Oct; 23(10):6775-6784. PubMed ID: 31429520
[TBL] [Abstract][Full Text] [Related]
14. Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder.
Dubosq F; Ploussard G; Soliman H; Turpin E; Latil A; Desgrandchamps F; de The H; Mongiat-Artus P
Urol Oncol; 2012; 30(6):833-40. PubMed ID: 21489836
[TBL] [Abstract][Full Text] [Related]
15. Prognosis prediction and risk stratification of breast cancer patients based on a mitochondria-related gene signature.
Wang Y; Wang DY; Bu KN; Gao JD; Zhang BL
Sci Rep; 2024 Feb; 14(1):2859. PubMed ID: 38310106
[TBL] [Abstract][Full Text] [Related]
16. Identification of glycolysis genes signature for predicting prognosis in malignant pleural mesothelioma by bioinformatics and machine learning.
Xiao Y; Huang W; Zhang L; Wang H
Front Endocrinol (Lausanne); 2022; 13():1056152. PubMed ID: 36523602
[TBL] [Abstract][Full Text] [Related]
17. A prognostic eight-lncRNA expression signature in predicting recurrence of ER-positive breast cancer receiving endocrine therapy.
Tang J; Cui Q; Zhang D; Kong D; Liao X; Ren J; Gong Y; Wu G
J Cell Physiol; 2020 May; 235(5):4746-4755. PubMed ID: 31663114
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population.
Xia R; Tang H; Shen J; Xu S; Liang Y; Zhang Y; Gong X; Min Y; Zhang D; Tao C; Wang S; Zhang Y; Yang J; Wang C
Cancer Cell Int; 2021 Mar; 21(1):154. PubMed ID: 33663535
[TBL] [Abstract][Full Text] [Related]
19. STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway.
Jiang W; Huang S; Song L; Wang Z
Oncol Rep; 2018 Feb; 39(2):834-842. PubMed ID: 29251330
[TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
